氨己烯酸哪里可以买？

Where can I buy vigabatrin? Vigadrone can be used as an auxiliary treatment for anti-epilepsy and for the auxiliary treatment of partial seizures in refractory complex epilepsy. Vigadrone can also be used to treat infantile spasms and Lennox-Gastaut syndrome, and for tardive dyskinesia. In August 2009, Vigadrone was approved for marketing by the FDA, and in January 2019, the FDA approved the marketing of a generic version of Vigadrone. It is understood that the current specification of Vigadrone produced by Sanofi in France is 500mg*100 tablets, and the price is around $1,500. The price may change due to various factors such as exchange rates. If patients want to know the specific price information of Vigadrone, or if they want to purchase the cost-effective drug overseas, they can consult with domestic reliable overseas medical service companies (such as Medical Companion Travel).

Vigadrone needs to be started under the guidance of a doctor with experience in treatment. The recommended dosage is as follows: the maximum dosage of Vigadrone for adults is 2-3g per day. It is appropriate to start taking Vigadrone at 1g per day. Then based on the response to the medication, if the response is good, it can be increased by 0.5g per week, and finally reaches a dose of 2-3g per day.

The recommended dosage for Vigadrone treatment in children is 40 mg/kg/day. Continuous medication should be judged according to the patient's weight. The recommended dosage for children weighing 10-15kg is 0.5-1g/day; the recommended dosage for 15-30kg is 1-1.5g/day; the recommended dosage for 30-50kg is 1.5-3g/day; >50kg 2-3g/day. If the patient has special circumstances, he or she needs to inform the doctor before starting treatment with Vigadrone, and the doctor will make adjustments to the patient's medication based on the actual situation to avoid harm to the patient due to incorrect medication.

Due to limited clinical reporting data on epilepsy and concomitant use of antiepileptic drugs, we cannot definitively conclude whether Sabrilex increases the risk of malformations during pregnancy. There is no data indicating that children may develop visual field defects in the fetus while taking Vigabatrin. Reproductive toxicity has emerged in experimental studies in animals. These relevant data are not yet known for humans. 

Generally, patients with uncontrolled epilepsy are not allowed to drive or operate potentially dangerous machinery. Given reports of drowsiness during clinical use of Sabrilex, patients should be warned before initiating treatment with Sabrilex.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: